Cancer clinical research faces a sea of change

Trials are more targeted, they incorporate technologies that exploit an ever increasing understanding of cancer biology, and new regulation are the horizon.

Europe’s clinical research ship is being outfitted to face this storm.

This conference will explore the interface between the Clinical Trial Regulation, expected to be applicable in 2016, and the In vitro Diagnostics and Data Protection regulations now being discussed by the EU Parliament and Council, and how these three regulations will influence cancer research practice.